IL161672A0 - Compositions and methods for therapy of chemotherapy-induced neuropathy - Google Patents

Compositions and methods for therapy of chemotherapy-induced neuropathy

Info

Publication number
IL161672A0
IL161672A0 IL16167204A IL16167204A IL161672A0 IL 161672 A0 IL161672 A0 IL 161672A0 IL 16167204 A IL16167204 A IL 16167204A IL 16167204 A IL16167204 A IL 16167204A IL 161672 A0 IL161672 A0 IL 161672A0
Authority
IL
Israel
Prior art keywords
chemotherapy
therapy
compositions
methods
induced neuropathy
Prior art date
Application number
IL16167204A
Other languages
English (en)
Original Assignee
Yeda Res & Dev
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yeda Res & Dev filed Critical Yeda Res & Dev
Priority to IL16167204A priority Critical patent/IL161672A0/xx
Publication of IL161672A0 publication Critical patent/IL161672A0/xx
Priority to ES05735913.5T priority patent/ES2444569T3/es
Priority to EP05735913.5A priority patent/EP1740199B1/en
Priority to US11/579,034 priority patent/US8394367B2/en
Priority to CA002563849A priority patent/CA2563849A1/en
Priority to JP2007510234A priority patent/JP4778507B2/ja
Priority to PCT/IL2005/000443 priority patent/WO2005105134A1/en
Priority to AU2005237323A priority patent/AU2005237323A1/en
Priority to IL178635A priority patent/IL178635A/en
Priority to NO20065473A priority patent/NO20065473L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/20—Interleukins [IL]
    • A61K38/204—IL-6
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Neurosurgery (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
IL16167204A 2004-04-29 2004-04-29 Compositions and methods for therapy of chemotherapy-induced neuropathy IL161672A0 (en)

Priority Applications (10)

Application Number Priority Date Filing Date Title
IL16167204A IL161672A0 (en) 2004-04-29 2004-04-29 Compositions and methods for therapy of chemotherapy-induced neuropathy
ES05735913.5T ES2444569T3 (es) 2004-04-29 2005-04-28 Quimera IL-6R/IL-6 para terapia de neuropatía periférica inducida por quimioterapia
EP05735913.5A EP1740199B1 (en) 2004-04-29 2005-04-28 Il6r/il6 chimera for therapy of chemotherapy-induced peripheral neuropathy
US11/579,034 US8394367B2 (en) 2004-04-29 2005-04-28 IL6R/IL6 chimera for therapy of chemotherapy-induced peripheral neuropathy
CA002563849A CA2563849A1 (en) 2004-04-29 2005-04-28 Il6r/il6 chimera for therapy of chemotherapy-induced peripheral neuropathy
JP2007510234A JP4778507B2 (ja) 2004-04-29 2005-04-28 化学療法誘発末梢性ニューロパシーの治療のためのｉｌ６ｒ／ｉｌ６キメラ
PCT/IL2005/000443 WO2005105134A1 (en) 2004-04-29 2005-04-28 Il6r/il6 chimera for therapy of chemotherapy-induced peripheral neuropathy
AU2005237323A AU2005237323A1 (en) 2004-04-29 2005-04-28 IL6R/IL6 chimera for therapy of chemotherapy-induced peripheral neuropathy
IL178635A IL178635A (en) 2004-04-29 2006-10-16 Use of il6r / il6 chimera for the preparation of drugs for the treatment of neuropathy caused by vinca-alkaloids
NO20065473A NO20065473L (no) 2004-04-29 2006-11-28 IL-6RL/IL-6-kimaerer for terapi av kjemoterapeutisk indusert perifer nevropati.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IL16167204A IL161672A0 (en) 2004-04-29 2004-04-29 Compositions and methods for therapy of chemotherapy-induced neuropathy

Publications (1)

Publication Number Publication Date
IL161672A0 true IL161672A0 (en) 2004-09-27

Family

ID=34074040

Family Applications (2)

Application Number Title Priority Date Filing Date
IL16167204A IL161672A0 (en) 2004-04-29 2004-04-29 Compositions and methods for therapy of chemotherapy-induced neuropathy
IL178635A IL178635A (en) 2004-04-29 2006-10-16 Use of il6r / il6 chimera for the preparation of drugs for the treatment of neuropathy caused by vinca-alkaloids

Family Applications After (1)

Application Number Title Priority Date Filing Date
IL178635A IL178635A (en) 2004-04-29 2006-10-16 Use of il6r / il6 chimera for the preparation of drugs for the treatment of neuropathy caused by vinca-alkaloids

Country Status (9)

Country Link
US (1) US8394367B2 (xx)
EP (1) EP1740199B1 (xx)
JP (1) JP4778507B2 (xx)
AU (1) AU2005237323A1 (xx)
CA (1) CA2563849A1 (xx)
ES (1) ES2444569T3 (xx)
IL (2) IL161672A0 (xx)
NO (1) NO20065473L (xx)
WO (1) WO2005105134A1 (xx)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL163856A0 (en) * 2004-09-01 2005-12-18 Applied Research Systems Use of IL-6 in vascular complications
CN107779436A (zh) * 2017-10-27 2018-03-09 南京中医药大学 化疗所致周围神经病变细胞模型构建及其检测方法
CN114470189B (zh) * 2020-11-12 2024-01-16 达石药业(广东)有限公司 Ngf抗体在cipn性疼痛中的应用

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69230789T3 (de) 1991-01-18 2007-10-31 Amgen Inc., Thousand Oaks Methoden zur behandlung von durch den tumor nekrose faktor ausgelösten krankheiten
IT1247484B (it) 1991-03-22 1994-12-17 Ceinge Societa Consortile A R Metodo per la preparazione di interleuchina 6
IT1277926B1 (it) * 1995-09-01 1997-11-12 Angeletti P Ist Richerche Bio Uso di muteine di citochine naturali come immunogeni per la preparazione di composizioni farmaceutiche per curare o prevenire
DE19608813C2 (de) 1996-03-07 1998-07-02 Angewandte Gentechnologie Syst Konjugat zur Beeinflussung von Wechselwirkungen zwischen Proteinen
US6063758A (en) 1997-07-09 2000-05-16 Advanced Targeting Systems, Inc. Substance P-Saporin (SP-SAP) conjugates and methods of use thereof
IL122818A0 (en) 1997-07-10 1998-08-16 Yeda Res & Dev Chimeric interleukin-6 soluble receptor/ligand protein analogs thereof and uses thereof
US20020058628A1 (en) 1998-06-09 2002-05-16 Noble Mark David Antioxidants and intracellular glutathione raising agents for therapeutic treatments
US20040170604A1 (en) 1998-07-06 2004-09-02 Tosoh Corporation IL-6 receptor IL-6 direct fusion protein
DE69927375T2 (de) 1998-07-06 2006-06-22 Tosoh Corp., Shinnanyo Fusionsprotein mit direkter verknüpfung des il-6-rezeptors mit il-6
IL130586A0 (en) 1999-06-21 2000-06-01 Yeda Res & Dev IL6RIL6 chimera for the treatment of demyelinating diseases
JP4944324B2 (ja) 1999-07-13 2012-05-30 ボルダー バイオテクノロジー， インコーポレイテッド 免疫グロブリン融合タンパク質
IL161310A0 (en) 2001-10-11 2004-09-27 Applied Research Systems Use of a substance signaling through gp 130 in pns disorders

Also Published As

Publication number Publication date
US8394367B2 (en) 2013-03-12
CA2563849A1 (en) 2005-11-10
JP2007534745A (ja) 2007-11-29
ES2444569T3 (es) 2014-02-25
JP4778507B2 (ja) 2011-09-21
NO20065473L (no) 2006-11-28
WO2005105134A1 (en) 2005-11-10
IL178635A (en) 2014-01-30
US20110274647A1 (en) 2011-11-10
AU2005237323A1 (en) 2005-11-10
EP1740199A1 (en) 2007-01-10
EP1740199B1 (en) 2014-01-01
IL178635A0 (en) 2007-02-11

Similar Documents

Publication Publication Date Title
EP1737482A4 (en) COMPOSITIONS AND METHODS FOR THE TREATMENT OF DISEASES
HK1110602A1 (en) Compositions and methods of using angiopoietin-like protein
IL184047A0 (en) Methods and compositions for treating amyloid-related diseases
EP1804832A4 (en) METHOD AND COMPOSITIONS FOR THE NADLESS DELIVERY OF MACROMOLECULES
EP1718331A4 (en) METHOD AND COMPOSITIONS FOR DOSING ALLERGENS
HK1119951A1 (en) Methods and compositions for oral administration of proteins
IL189364A0 (en) Estrogen compositions and therapeutic methods of use thereof
EP1966246A4 (en) METHOD AND COMPOSITIONS FOR NEEDLE-FREE ADMINISTRATION OF ANTIBODIES
EP1812031A4 (en) COMPOSITIONS AND METHOD FOR MODIFYING BIOMOLECULES
IL191072A0 (en) Therapeutic compositions and methods
EP1796666A4 (en) METHOD AND COMPOSITIONS FOR TREATING HYPERLIPIDEMIA
IL183017A0 (en) Stabilized ramipril compositions and methods of making
EP1763358A4 (en) COMPOSITIONS AND METHODS CUT-HUNGER
IL179931A0 (en) Compositions and methods for treatment of cardiovascular disease
IL183709A0 (en) Compositions and methods for treating conditions of the nail unit
IL182943A0 (en) Ovr110 antibody compositions and methods of use
ZA200705297B (en) Methods and compositions for treating amyloid related diseases
EP1786265A4 (en) NEW COMPOSITIONS AND PROCESSING METHODS
EP1773386A4 (en) VACCINE COMPOSITIONS AND CORRESPONDING METHODS
IL186325A0 (en) Tizanidine compositions and methods of treatment using the compositions
EP1720563A4 (en) METHODS AND COMPOSITIONS FOR TREATING INFLAMMATION
HK1109576A1 (en) Aequorin-containing compositions and methods of using same
IL178636A0 (en) Compositions and methods for therapy of chemotherapy-induced neuropathy
GB0608398D0 (en) Pharmaceutical composition and method of using same
EP1773349A4 (en) METHODS AND COMPOSITIONS FOR TREATING PREECLAMPSIA